The clearance marks a pivotal step forward for the company as it pushes deeper into AI-driven diagnostics and expands its clinical footprint in point-of-care imaging
The company highlighted a series of strategic moves during the year, including the acquisition of WOKADINE, marking its entry into the Rs. 648 Cr Povidone Iodine market
75 bikers participated in the rally organised by Thalassemia and Sickle Cell Society to promote early screening and voluntary blood donation
The CDMO segment saw a 22% decline in Q4 due to a strong base in the prior year
The ultrasound-based AI imaging platform is designed to support rapid fracture detection and soft tissue injury assessment in emergency care settings
The Union Minister reviewed DST-supported SATHI-BHU facility
India’s institutions now need to upgrade TTOs as strategic innovation units rather than administrative support cells
Strong export-led growth and improved profitability as the company focuses on CNS drug development and global regulatory footprint
Healthcare leaders, policymakers, hospitals, and patient advocates discuss AI-driven healthcare, digital transformation, quality of life in cancer care
The six-part webinar series aims to enhance awareness, diagnosis, and management of autoimmune diseases
Subscribe To Our Newsletter & Stay Updated
